Add office photos
Employer?
Claim Account for FREE
Aurobindo Pharma
4.0
based on 4.7k Reviews
Company Overview
Associated Companies
Company Locations
Working at Aurobindo Pharma
Company Summary
Aurobindo Pharma operates in the pharmaceutical sector, specializing in cost-efficient manufacturing of active ingredients and formulations across diverse therapeutic areas.
Overall Rating
4.0/5
based on 4.7k reviews
3% above
industry average
Highly rated for
Job security, Salary, Work-life balance
Work Policy
Work from office
90% employees reported
Monday to Saturday
58% employees reported
Strict timing
53% employees reported
No travel
43% employees reported
View detailed work policy
Top Employees Benefits
Job/Soft skill training
257 employees reported
Health insurance
245 employees reported
Office cab/shuttle
185 employees reported
Cafeteria
86 employees reported
View all benefits
About Aurobindo Pharma
Founded in1986 (39 yrs old)
India Employee Count10k-50k
Global Employee Count10k-50k
India HeadquartersHyderabad/Secunderabad, Telangana, India
Office Locations
--
Websiteaurobindo.com
Primary Industry
Other Industries
Are you managing Aurobindo Pharma's employer brand? To edit company information,
claim this page for free
Founded in 1986 by Mr. P.V. Ramprasad Reddy, Mr. K. Nityananda Reddy and a small group of highly committed professionals, Aurobindo Pharma was born of a vision. The company commenced operations in 1988-89 with a single unit manufacturing Semi-Synthetic Penicillin (SSP) at Pondicherry. Aurobindo Pharma became a public company in 1992 and listed its shares on the Indian stock exchanges in 1995. In addition to being the market leader in Semi-Synthetic Penicillin’s, Aurobindo Pharma has a presence in key therapeutic segments such as neurosciences (CNS), cardiovascular (CVS), anti-retroviral, anti-diabetics, gastroenterology and Anti-biotics Through cost effective manufacturing capabilities and a few loyal customers, the company also entered the high margin specialty generic formulations segment. Today Aurobindo Pharma has evolved into a knowledge driven company manufacturing active pharmaceutical ingredients and formulation products. It is R&D focused and has a multi-product portfolio with manufacturing facilities in several countries.
Mission: Aurobindo’s mission is to become the most valued Pharma partner to the World Pharma fraternity by continuously researching, developing and manufacturing a wide range of pharmaceutical products that comply with the highest regulatory standards.
Vision: To build a leading global generic pharma company and become one of the top 10 by 2020.
Managing your company's employer brand?
Claim this Company Page for FREE
Brands of Aurobindo Pharma
Apis India
3.7
• 130 reviews
AuroZymes
3.0
• 1 review
Aurobindo Pharma Ratings
based on 4.7k reviews
Overall Rating
4.0/5
How AmbitionBox ratings work?
5
2.2k
4
1.4k
3
559
2
201
1
297
Category Ratings
4.3
Job security
3.8
Salary
3.8
Work-life balance
3.7
Work satisfaction
3.6
Skill development
3.5
Company culture
3.5
Promotions
Aurobindo Pharma is rated 4.0 out of 5 stars on AmbitionBox, based on 4.7k company reviews. This rating reflects a generally positive employee experience, indicating satisfaction with the company’s work culture, benefits, and career growth opportunities. AmbitionBox gathers authentic employee reviews and ratings, making it a trusted platform for job seekers and employees in India.
Read more
Gender Based Ratings at Aurobindo Pharma
based on 4.4k reviews
4.1
Rated by 211 Women
Rated 4.2 for Job security and 3.8 for Work satisfaction
4.0
Rated by 4.2k Men
Rated 4.3 for Job security and 3.8 for Work-life balance
Work Policy at Aurobindo Pharma
based on 423 reviews in last 6 months
Work from office
90%
Hybrid
6%
Permanent work from home
4%
Aurobindo Pharma Reviews
Top mentions in Aurobindo Pharma Reviews
+ 5 more
Compare Aurobindo Pharma with Similar Companies
Change Company | Change Company | Change Company | ||
|---|---|---|---|---|
Overall Rating | 4.0/5 based on 4.7k reviews | 4.0/5 based on 5.7k reviews | 4.1/5 based on 6.7k reviews | 5.0/5 based on 1 reviews |
Highly Rated for | Job security Work-life balance Salary | Salary Job security Skill development | Skill development Salary Work-life balance | Skill development Work-life balance Salary |
Critically Rated for | No critically rated category | No critically rated category | No critically rated category | No critically rated category |
Primary Work Policy | Work from office 90% employees reported | Work from office 83% employees reported | Work from office 72% employees reported | - |
Rating by Women Employees | 4.1 Good rated by 211 women | 4.0 Good rated by 420 women | 4.1 Good rated by 654 women | - no rating available |
Rating by Men Employees | 4.0 Good rated by 4.2k men | 4.0 Good rated by 4.9k men | 4.1 Good rated by 5.7k men | - no rating available |
Job security | 4.3 Good | 3.9 Good | 3.7 Good | 4.0 Good |
View more
Aurobindo Pharma Salaries
Aurobindo Pharma salaries have received with an average score of 3.8 out of 5 by 4.7k employees.
Technical Assistant
(1.2k salaries)
Unlock
₹1.5 L/yr - ₹6.8 L/yr
Deputy Manager
(514 salaries)
Unlock
₹7 L/yr - ₹17.5 L/yr
Senior Technical Assistant
(378 salaries)
Unlock
₹3.2 L/yr - ₹8.3 L/yr
Research Associate
(296 salaries)
Unlock
₹1.8 L/yr - ₹9.3 L/yr
Executive Production
(237 salaries)
Unlock
₹1.8 L/yr - ₹10.8 L/yr
Scientist
(181 salaries)
Unlock
₹6 L/yr - ₹14.5 L/yr
Research Associate IV
(177 salaries)
Unlock
₹3.4 L/yr - ₹9.4 L/yr
Senior Chemist
(171 salaries)
Unlock
₹3 L/yr - ₹7 L/yr
Executive Engineer
(158 salaries)
Unlock
₹2 L/yr - ₹8.6 L/yr
QA Executive
(149 salaries)
Unlock
₹2.5 L/yr - ₹8 L/yr
Aurobindo Pharma Interview Questions
Interview questions by designation
Top Aurobindo Pharma interview questions and answers
Get interview-ready with top interview questions
Aurobindo Pharma Jobs
Aurobindo Pharma News
View all
Stocks that will see action today: February 1
- Hero MotoCorp appoints Vikram Kasbekar as acting CEO, Niranjan Gupta to step down
- Onesource Specialty Pharma promoters divest 6.8% stake for Rs 1,202 crore
- CL Educate acquires Digital Exam Assessment business of NSEIT
- Aurobindo Pharma's subsidiary receives positive opinion for Dyrupeg from CHMP
HinduBusinessLine | 1 Feb, 2025
Stock Market On Budget Day: All You Need To Know Going Into Trade On Feb. 1
- Both NSE and BSE will remain open on Saturday, Feb. 1 on account of the Budget Day.
- Indian equity benchmark indices closed higher four days in a row, Nifty ended 1.12% and BSE Sensex ended 0.97% higher.
- Foreign portfolio investors stayed net sellers of Indian equities for the 21st straight session on Friday as they sold stocks worth approximately Rs 1,189 crore.
- Earnings To Watch: Aarti Industries, Anant Raj, Ganesha Ecosphere, GR Infraprojects, Jaiprakash Power Ventures, Neogen Chemicals and Vinati Organics.
- Stocks To Watch: ONGC, Waaree Energies, Nestle India, Aurobindo Pharma, Hero MotoCorp, Punjab National Bank, Britannia, Tata Power, GAIL, Ganesha Ecosphere and Sundaram Clayton.
- Nifty February futures end 0.94% higher at a premium of 111 points.
- The Indian rupee closed flat against the US dollar on Friday at 86.62.
- Indian Finance Minister Nirmala Sitharaman will announce the Budget 2025 on Feb. 1.
- Most Asian markets will remain closed on Saturday.
- Indian stock markets will remain open on Feb. 1.
Bloomberg Quint | 1 Feb, 2025
Stocks To Buy Today: Dr Reddy's, BHEL HCC, Aurobindo Pharma And More
- Analysts have shared 'buy' calls on BHEL, HCC, Dr Reddy's, Aurobindo Pharma, IPCA Labs, and Laurus Labs.
- Some of these companies could see upside of as much as 9% in the near term from current levels.
- Top stocks to buy, as recommended by experts: Dr Reddy's Laboratories, Aurobindo Pharma, Laurus Labs, HCC, IPCA Laboratories.
- Stocks like Dr Reddy's and Aurobindo Pharma have shown significant gains in the past 12 months.
Bloomberg Quint | 30 Dec, 2024
Buy, Sell Or Hold: M&M, IOC, Asian Paints, Oil India, Varun Beverages — Ask Profit
- Market analysts provide insights for short-term and long-term investors on buying, selling, or holding shares of Shakti Pumps, Varun Beverages, and others.
- KPIT Technologies: Analyst suggests selling on rise as downside potential is expected.
- Aurobindo Pharma: Analyst recommends buying, stating it as a good stock for the long term.
- Indian Oil Corp: Analyst advises holding due to attractive dividend yield and potential upside in the long term.
- Asian Paints: Analyst suggests selling on rise as the stock shows a lower-high, lower-top pattern.
- M&M: Analyst recommends holding, citing strong sales demand and low consumption.
- Oil India: Analyst suggests holding for long term, as the stock corrects from high levels.
- Shakti Pumps: Analyst suggests selling in the short term and holding for the long term.
- Varun Beverages: Analyst advises holding, as the stock consolidates and has potential for a bullish trend.
Bloomberg Quint | 24 Dec, 2024
Aurobindo Pharma, Glenmark, Zydus Recall Products In US
- Drug makers Aurobindo Pharma, Glenmark, and Zydus are recalling products in the US market due to manufacturing issues.
- Aurobindo Pharma USA Inc. is recalling over 1 lakh bottles of Cinacalcet tablets due to the presence of N-nitroso Cinacalcet impurity above FDA recommended limit.
- Glenmark Pharmaceuticals Inc, USA is recalling around 90,000 bottles of Diltiazem Hydrochloride extended-release capsules due to the presence of N-nitroso-Desmethyl-Diltiazem impurity above FDA recommended limit.
- Zydus Pharmaceuticals (USA) Inc is recalling 4,404 packs of Esomeprazole Magnesium for Delayed-Release Oral Suspension due to a labeling error.
Bloomberg Quint | 15 Dec, 2024
Aurobindo Pharma, Glenmark recall products in US
- Aurobindo Pharma USA Inc, Glenmark Pharmaceuticals Inc, USA, and Zydus Pharmaceuticals (USA) Inc are recalling products in the US market due to manufacturing issues.
- Aurobindo Pharma is recalling over 1 lakh bottles of Cinacalcet tablets due to the presence of N-nitroso Cinacalcet impurity above FDA recommended interim limit.
- Glenmark Pharmaceuticals is recalling around 90,000 bottles of Diltiazem Hydrochloride extended-release capsules due to the presence of N-nitroso-Desmethyl-Diltiazem impurity above FDA recommended interim limit.
- Zydus Pharmaceuticals is recalling 4,404 packs of Esomeprazole Magnesium for Delayed-Release Oral Suspension due to a labelling error.
Yourstory | 15 Dec, 2024
Aurobindo, Glenmark, Zydus recall products in US over manufacturing issues
- Aurobindo Pharma USA Inc is recalling over 1 lakh bottles of Cinacalcet tablets in multiple strengths due to manufacturing issues.
- Glenmark Pharmaceuticals Inc, USA is recalling around 90,000 bottles of Diltiazem Hydrochloride extended-release capsules (multiple strengths) due to the presence of certain impurities.
- Zydus Pharmaceuticals (USA) Inc is recalling 4,404 packs of Esomeprazole Magnesium for Delayed-Release Oral Suspension (40 mg) due to a labelling error.
- These recalls were initiated by the companies as per the guidelines of the USFDA to ensure consumer safety.
HinduBusinessLine | 15 Dec, 2024
Cipla To Sun Pharma: Here Are HSBC's Top Pharma Stock Picks
- HSBC has identified its top picks in the Indian pharmaceutical sector, maintaining a buy rating on Cipla Ltd., Sun Pharmaceutical Industries Ltd., Lupin Ltd., Torrent Pharmaceuticals Ltd., and Aurobindo Pharma Ltd.
- HSBC believes the loss of gRevlimid sales from January 2026 is already priced into the valuations for Cipla and Sun Pharma.
- Stable generic pricing and the execution of key product launches in the US are expected to drive performance in 2025.
- Increasing focus on complex generics and GLP-1 drugs, such as liraglutide, is also seen as crucial for sustaining growth in the US market.
Bloomberg Quint | 11 Dec, 2024
Nifty Pharma, Healthcare Snap Two-Day Fall Post Jefferies' Outlook
- Nifty Pharma and Nifty Healthcare snapped their two-day fall and rose on Tuesday, following a report by Jefferies on its takeaways from its tour of pharma companies across Delhi, Mumbai, and Hyderabad.
- The report mentioned that non-price metrics are being given due importance for supplier selection and hospitals are looking to add new geographies once the home turf is well protected.
- Indian generic firms with meaningful exposure to the US market are adopting different strategies to avoid price erosion, such as moving up the value chain and pursuing complex products.
- In Nifty Healthcare, Glenmark Pharma, Syngene International, and Apollo Hospitals were among the top gainers, while Dr Reddy's Labs, Zydus Lifesciences, and Aurobindo Pharma fell the most.
Bloomberg Quint | 10 Dec, 2024
Aurobindo Pharma wins USFDA approval for generic cancer drug
- Aurobindo Pharma has received approval from the USFDA for its generic cancer drug, bioequivalent to Novartis Pharmaceuticals’ Votrient Tablets.
- The drug is indicated for treating advanced Renal Cell Carcinoma (RCC) and Soft Tissue Sarcoma (STS) in adult patients who have undergone prior chemotherapy.
- The estimated market size for the drug is around US$ 106 million, and Aurobindo plans to launch it in the fourth quarter of fiscal year 2025.
- This approval marks the 179th Abbreviated New Drug Application (ANDA) for Eugia Pharma Specialities Group, the manufacturer of the drug.
HinduBusinessLine | 5 Dec, 2024
Powered by
Aurobindo Pharma Subsidiaries
Eugia Pharma Specialities
4.1
• 408 reviews
APL Healthcare
3.7
• 47 reviews
Auro Peptides
4.3
• 32 reviews
Silicon Life Sciences
4.3
• 7 reviews
Tergene Biotech
1.7
• 2 reviews
APL RESEARCH CENTRE
4.4
• 2 reviews
Report error
Aurobindo Pharma Offices
Compare Aurobindo Pharma with
Biocon Limited
3.9
Lupin
4.2
Zydus Lifesciences
4.1
Glenmark Pharmaceuticals
3.9
Torrent Pharmaceuticals
3.9
DIVI'S Laboratories
3.8
Alembic Pharmaceuticals
4.0
Dr. Reddy's
4.1
Viatris
4.2
Abbott
4.1
Alkem Laboratories
3.9
Ipca Laboratories
4.0
Ajanta Pharma
4.0
Akums Drugs & Pharmaceuticals Limited
4.4
Cadila Pharmaceuticals
3.5
GlaxoSmithKline Pharmaceuticals
4.1
Pfizer
4.0
Wockhardt
3.9
Piramal Group
3.8
Sanofi
4.3
Edit your company information by claiming this page
Contribute & help others!
You can choose to be anonymous
Companies Similar to Aurobindo Pharma
Sun Pharmaceutical Industries
Healthcare / Pharma, Manufacturing, Analytics & KPO, Pharma
4.0
• 5.7k reviews
DRJ & CO
Architecture & Interior Design
5.0
• 1 reviews
Cipla
Manufacturing, Pharma
4.1
• 6.7k reviews
Biocon Limited
Biotech & Life sciences, Biotechnology
3.9
• 1.8k reviews
Lupin
Biotech & Life sciences, Manufacturing, Pharma
4.2
• 5.9k reviews
Zydus Lifesciences
Biotech & Life sciences, Pharma
4.1
• 5.9k reviews
Glenmark Pharmaceuticals
Pharma
3.9
• 2.8k reviews
Torrent Pharmaceuticals
Pharma
3.9
• 2.4k reviews
DIVI'S Laboratories
Pharma
3.8
• 1.3k reviews
Alembic Pharmaceuticals
Real Estate, Engineering & Construction, Biotechnology, Pharma
4.0
• 3k reviews
Dr. Reddy's
Clinical Research, Pharma
4.1
• 6.6k reviews
Viatris
Manufacturing, Pharma
4.2
• 3k reviews
Aurobindo Pharma FAQs
When was Aurobindo Pharma founded?
Aurobindo Pharma was founded in 1986. The company has been operating for 39 years primarily in the Pharma sector.
Where is the Aurobindo Pharma headquarters located?
Aurobindo Pharma is headquartered in Hyderabad/Secunderabad, Telangana.
How many employees does Aurobindo Pharma have in India?
Aurobindo Pharma currently has more than 26,000+ employees in India. Research & Development department appears to have the highest employee count in Aurobindo Pharma based on the number of reviews submitted on AmbitionBox.
Does Aurobindo Pharma have good work-life balance?
Aurobindo Pharma has a Work-Life Balance Rating of 3.8 out of 5 based on 4,600+ employee reviews on AmbitionBox. 77% employees rated Aurobindo Pharma 4 or above, while 23% employees rated it 3 or below on work-life balance. This indicates that the majority of employees feel a generally balanced work-life experience, with some opportunities for improvement based on the feedback. We encourage you to read Aurobindo Pharma work-life balance reviews for more details
Is Aurobindo Pharma good for career growth?
Career growth at Aurobindo Pharma is rated fairly well, with a promotions and appraisal rating of 3.5. 77% employees rated Aurobindo Pharma 4 or above, while 23% employees rated it 3 or below on promotions/appraisal. Though the sentiment is mixed for career growth, majority employees have rated it positively. We recommend reading Aurobindo Pharma promotions/appraisals reviews for more detailed insights.
What are the pros of working in Aurobindo Pharma?
Working at Aurobindo Pharma offers several advantages that make it an appealing place for employees. The company is highly rated for job security, salary & benefits and work life balance, based on 4,600+ employee reviews on AmbitionBox.
Stay ahead in your career. Get AmbitionBox app
Helping over 1 Crore job seekers every month in choosing their right fit company
70 Lakh+
Reviews
5 Lakh+
Interviews
4 Crore+
Salaries
1 Cr+
Users/Month
Contribute to help millions
Get AmbitionBox app
Made with ❤️ in India. Trademarks belong to their respective owners. All rights reserved © 2024 Info Edge (India) Ltd.
Follow us
